| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848878 | American Journal of Kidney Diseases | 2012 | 9 Pages |
Abstract
For female patients with CKD, treatment with bisphosphonates is associated with a lower risk of death, but not cardiovascular events. Confirmatory studies and investigations of potential causal mechanisms are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
James E. MD, Xiaoqin PhD, H. Lester PhD, Ion D. MD, Jennifer A. MS, Zhanna V. MD, Gwendolyn A. DO, Guillermo E. MD, Robert M. MD,